Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics

John K Lin; Pengxiang Li; Jalpa A Doshi; Sunita M Desai

doi:10.1001/jamahealthforum.2022.1435

Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics

JAMA Health Forum. 2022 Jun 17;3(6):e221435. doi: 10.1001/jamahealthforum.2022.1435. eCollection 2022 Jun.

Authors

John K Lin^{1

2

3}, Pengxiang Li¹, Jalpa A Doshi^{1

2}, Sunita M Desai⁴

Affiliations

¹ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
³ Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
⁴ Department of Population Health, School of Medicine, New York University, New York.

Abstract

This cross-sectional study assesses pharmacy participation in the 340B Drug Pricing Program following the 2010 expansion and the extent to which growth has occurred in socioeconomically disadvantaged neighborhoods.

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Costs and Cost Analysis
Cross-Sectional Studies
Drug Costs
Pharmacies*
Socioeconomic Factors

Abstract

Publication types

MeSH terms

Grants and funding